Paper20041830
Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells.
El Gendy MA and 1 other. Drug Metab Lett, 2009. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Papers, record 20041830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20041830
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Peganum harmala L. differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochrome P-450 Enzyme System | Major topic |
| Peganum | Major topic |
| Plant Extracts | Major topic |
| Dose-Response Relationship, Drug | |
| Gene Expression | |
| Hep G2 Cells | |
| Humans | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40634953 | Commiphora myrrha resin extract-modulated cytochrome P-450 2C9 enzyme expression in cultured Hep G2 cells is associated with resin extract-derived metabolites binding to Pregnane X receptor. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/40634953 | PubMed |
| 40352903 | Boswellia carteri Birdw. Resin Extract Induces Phase-I Cytochrome P-450 Enzyme Gene Expressions in Human Hepatocarcinoma (Hep G2) Cells: In vitro and in silico Studies. | Biologics | 2025 | https://conductscience.org/library/papers/40352903 | PubMed |
| 34135662 | Commiphora myrrha (Nees) Engl. resin extracts induce phase-I cytochrome P450 2C8, 2C9, 2C19, and 3A4 isoenzyme expressions in human hepatocellular carcinoma (HepG2) cells. | Saudi Pharm J | 2021 | https://conductscience.org/library/papers/34135662 | PubMed |
| 32905276 | Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer. | ACS Omega | 2020 | https://conductscience.org/library/papers/32905276 | PubMed |
| 26903865 | Different Contribution of Redox-Sensitive Transient Receptor Potential Channels to Acetaminophen-Induced Death of Human Hepatoma Cell Line. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/26903865 | PubMed |
| 24347928 | Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. | Pharmacogn Rev | 2013 | https://conductscience.org/library/papers/24347928 | PubMed |
| 23509697 | Harmine and harmaline downregulate TCDD-induced Cyp1a1 in the livers and lungs of C57BL/6 mice. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23509697 | PubMed |
| 22037238 | Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. | Food Chem Toxicol | 2012 | https://conductscience.org/library/papers/22037238 | PubMed |
| 22001777 | Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol. | Toxicol Lett | 2012 | https://conductscience.org/library/papers/22001777 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP2B6 | 1555 | PubTator's text mining | https://conductscience.org/library/genes/1555 | NCBI Gene |
| CYP2D6 | 1565 | PubTator's text mining | https://conductscience.org/library/genes/1565 | NCBI Gene |
| CYP2E1 | 1571 | PubTator's text mining | https://conductscience.org/library/genes/1571 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20041830
GET https://conductscience.org/api/papers/v1/20041830/authors